14-15 NOVEMBER 2024

Portfolio Events
26 Aug 2022

Stromease - A Unique, Licensed Treatment for Corneal Ulcers in Dogs and Cats

Stromease - A Unique, Licensed Treatment for Corneal Ulcers in Dogs and Cats
Stromease -

Corneal ulcers are a common occurrence and have a number of causes such as trauma, foreign bodies or underlying ocular pathology such as tear film insufficiency.

Keratomalacia, or corneal melting, may develop as a complication of an existing corneal ulcer due to the uncontrolled action of proteolytic enzymes.  This can lead to corneal perforation and permanent loss of vision. Management of keratomalacia requires prompt and aggressive medical treatment to arrest corneal destruction.

Anti-collagenases, anti-microbials and analgesia are the mainstay of medical therapy, with surgical intervention also indicated for cases requiring tectonic support. In addition, certain patients (such as brachycephalic breeds) are more at risk of keratomalacia occurring, therefore anti-collagenases should be considered pre-emptively as part of the treatment plan.

Stromease, the first and only licensed product of its type, contains the active ingredient N-acetylcysteine. As it does not require any prior preparation or special storage, it is convenient for prescriber, pet owner and patient.

Presented in an easy-to-use 5ml bottle, Stromease has a three-year unopened shelf-life. The licensed dose is two drops into the affected eye(s) 3-4 times daily.


Education Partner

Platinum Sponsor

Gold Sponsor

Silver Sponsor

Media Sponsors

Be the leader of your pack

Be the first to hear the latest news, programme updates and exclusive industry releases.



Global Portfolio

BVA Live

6-7 June 2024

Deutsche Vet

7-8 June 2024

Singapore Vet

25-26 October 2024

Wild West Vet

16-19 October 2024

New York Vet

7-8 November 2024